is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity.

’s lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage development for hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI), including congenital hyperinsulinism (cHI), the most common cause of persistent hypoglycemia in infants and children.

• Ensure activities adhere to SOPs, regulatory standards, and industry codes of practice.
• Contribute to SOPs and work instructions for SRDs, Medical Information, and grants. Partner with pharmacovigilance on reporting of adverse events and product complaints received through Medical Information

• PharmD, PhD, MD, or other advanced scientific degree.
• Hands-on experience developing SRDs and Medical Information responses.
• Experience serving as a Medical Affairs reviewer in MLR/PRC.
• Working knowledge of medical education grant processes, ACCME standards, and applicable industry codes and transparency requirements.
• Ability to translate complex scientific data into clear, accurate, and balanced content.
• Strong project management and attention to detail, with the ability to manage multiple deliverables and vendors.
• Strong communication and collaboration skills in a fast-paced, matrixed organization.
• Willingness to travel domestically (up to approximately 20%).

(RZLT) currently anticipates the base salary for Senior Manager, Scientific Communications & Medical Education role could range from $180,000 to $225,000 and will depend, in part, on the successful candidate’s geographical location and their qualifications for the role, including education and experience. This position will also be eligible for an annual performance bonus in accordance with the terms of the applicable plan (depending, in part, on company and individual performance and at the Company’s discretion on an individual basis). The compensation described above is subject to change and could be higher or lower than the range described based on current market survey data and the qualifications, education, experience and geographical location of the selected candidate. offers competitive compensation, stock options and a rich benefits package.

Qualifying employees are eligible to participate in benefit programs such as:

We are an Equal Opportunity Employer and do not discriminate against applicants due to race, ethnicity, gender, veteran status, or on the basis of disability or any other federal, state or local protected class.